Treatment of Advanced Colorectal Cancer with High-dose Intensity Folinic Acid and 5-Fluorouracil Plus Supportive Care

By Petrioli R.   Lorenzi M.   Aquino A.   Marsili S.   Frediani B.   Palazzuoli V.   Marzocca G.   Botta G.   Tani F.   De Martino A.   Testi W.   Setacci C.   Salvestrini F.   De Sando D.   Bovenga S.   Mariani L.   Mancini S.   Tanzini G.   Armenio S.   Marinello E.   Francini G.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2105-2108

Elsevier

Access to resources Recommend Favorite

Efficacy of Oral Tegafur Modulation by Uracil and Leucovorin in Advanced Colorectal Cancer. A Phase II Study

By Gonzalez-Baron M.   Feliu J.   de la Gandara I.   Espinosa E.   Colmenarejo A.   Martinez-Martinez B.   Blanco E.   Garcia-Giron C.   Juarez F.   Garrido P.   Ordonez A.   Zamora P.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2215-2219

Elsevier

Access to resources Recommend Favorite

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 951-959

Spandidos Publications

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen

By Raderer M.   Kornek G.V.   Hejna M.H.L.   Miholic J.   Weinlaender G.   Brodowicz T.   Fiebiger W.C.C.   Valencak J.B.   Scheithauer W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1128-1130

Elsevier

Access to resources Recommend Favorite